Sector Chart Lexicon Pharmaceuticals, Inc.

Stocks

LXRX

US5288723027

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 00:17:45 04/11/2026 +04			5-day change	1st Jan Change
1.465 ^USD	+1.74%		-0.68%	+27.83%

10-23	Lexicon Pharmaceuticals, Inc. Provides Update On Baseline Patient Characteristics For Pivotal Phase 3 SONATA-HCM Study Of Sotagliflozin In Symptomatic Hypertrophic Cardiomyopathy	CI
10-23	Lexicon Says Sotagliflozin Trial Exceeds Enrollment Goal With 542 Patients	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes